Why the study?
Does market availability of antihypertensive medications affect adherence in patients ≥40 years of age?
Population
36,214 subjects ≥40 years of age who received a new antihypertensive medication between 1994 and 2002 in…
Comparison
Antihypertensive medications and their market… vs Other antihypertensive agents and different…
Design
Cohort
Follow-up
1 year
Authors
Loading...
Market availability was associated with optimal ACEI/ARB adherence; leaves open causal role versus tolerability in observational cohorts.
Does market availability of antihypertensive medications affect adherence in patients ≥40 years of age?
Optimal adherence to ACEIs and ARBs may be associated with their relative market availability rather than solely improved tolerability.
Evans et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: